Table 2 Factors associated with progression-free survival (PFS) in univariate analysis.

From: Impact of sarcopenia in patients with advanced non–small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study

 

HR (95% CI)

p-value

Age

   <70 years

Reference

 

   ≥70 years

1.09 (0.55–2.16)

0.81

Sex

   Female

Reference

 

   Male

2.54 (1.21–5.33)

0.014

ECOG PS

   0–1

Reference

 

   ≥2

2.44 (1.07–5.59)

0.030

Smoking history

   Never smoker

Reference

 

   Current or former smoker

1.54 (0.75–3.16)

0.24

Histology

   Non-squamous

Reference

 

   Squamous

1.32 (0.63–2.76)

0.47

Sarcopenia

   No

Reference

 

   Yes

2.83 (1.35–5.95)

0.004

  1. Abbreviations: HR, hazard ratio; CI, confidence interval; ECOG PS, Eastern Cooperative Oncology Group performance status.
Back to article page